(Alliance News) - Faron Pharmaceuticals Oy on Thursday said it has applied to list is shares on Nasdaq First North Growth Market.
Faron's shares are currently traded on London's AIM market via depositary interest, and these were up 9.8% at 195.50 pence on Thursday afternoon.
Nasdaq First North Growth is a multilateral trading facility and is operated by Nasdaq Helsinki Ltd, it is intended to help Nordic and international companies to increase investor visibility in preparation for a listing on the regulated Nasdaq Main Market.
Should the application prove successful, clinical stage biopharmaceutical firm Faron expects its first day of Nasdaq First North trading to be December 3.
By Anna Farley; email@example.com
Copyright 2019 Alliance News Limited. All Rights Reserved.